Breaking News

Abselion Launches AAVX and AAV9 Quantification Kits

Supports rapid, reliable quantification across a range of serotypes.

Author Image

By: Charlie Sternberg

Associate Editor

Abselion’s AAVX and AAV9 Total Capsid Quantification Kits.

Abselion, a life sciences technology company focused on simplifying biomolecule quantification, has expanded its product offering with the launch of the AAVX Total Capsid Quantification Kit and the AAV9 Total Capsid Quantification Kit. Both kits are designed for use with its Amperia benchtop quantification platform and include Thermo Fisher Scientific’s CaptureSelect affinity reagents. Combining these reagents with Abselion’s consistent assay format reduces the need for in-house optimization....

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics